Literature DB >> 18235080

Apolipoprotein E genotype and memory in the sixth decade of life.

M R Schultz1, M J Lyons, C E Franz, M D Grant, C Boake, K C Jacobson, H Xian, G D Schellenberg, S A Eisen, W S Kremen.   

Abstract

BACKGROUND: Virtually all adult studies of APOE genotypes and cognition have included individuals over 60. In older adults, epsilon 4 carriers may manifest greater cognitive asymmetries than non-epsilon 4 carriers even in the absence of overall mean differences. General cognitive ability may also be affected by aging and APOE genotype, but most studies have inadequately addressed this potential confound. The goals of this study were to examine, in middle age, the relationship of APOE genotype with episodic memory and verbal-visuospatial episodic memory asymmetries, after accounting for prior general cognitive ability.
METHOD: We compared epsilon 4+ and epsilon 4- individuals in 626 male twins in their 50s. We examined verbal and visuospatial episodic memory and verbal-visual asymmetry scores after adjusting for cognitive ability at age 20. Analyses corrected for correlations between twin pair members.
RESULTS: Compared with epsilon 4- individuals, epsilon 4 carriers performed significantly more poorly on verbal, but not visuospatial memory, manifested significantly greater cognitive asymmetry, and also had significantly more concerns about memory. At age 20, epsilon 4 carriers had higher general cognitive ability than epsilon 4- individuals, and current memory differences were enhanced after adjusting for age 20 cognitive ability.
CONCLUSIONS: Small, but significant, APOE-epsilon 4-related memory deficits appear in the sixth decade of life in individuals who show no signs of preclinical dementia. The results partially support studies of older adults that suggest that increased cognitive asymmetries reflect risk for dementia and are associated with the APOE-epsilon 4 genotype. The results also highlight the potential problems of not having accurate data on prior cognitive ability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18235080      PMCID: PMC3107734          DOI: 10.1212/01.wnl.0000286941.74372.cc

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  APOE genotype and cognitive decline in a middle-aged cohort.

Authors:  C K Blair; A R Folsom; D S Knopman; M S Bray; T H Mosley; E Boerwinkle
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

2.  Genes, environment, and time: the Vietnam Era Twin Study of Aging (VETSA).

Authors:  William S Kremen; Heather Thompson-Brenner; Yat-Ming J Leung; Michael D Grant; Carol E Franz; Seth A Eisen; Kristen C Jacobson; Corwin Boake; Michael J Lyons
Journal:  Twin Res Hum Genet       Date:  2006-12       Impact factor: 1.587

3.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

4.  Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Authors:  M G Dik; C Jonker; H C Comijs; L M Bouter; J W Twisk; G J van Kamp; D J Deeg
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

5.  The Vietnam Era Twin (VET) Registry: ascertainment bias.

Authors:  J Goldberg; W True; S Eisen; W Henderson; C D Robinette
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1987

6.  The Vietnam Era Twin (VET) Registry: method of construction.

Authors:  S Eisen; W True; J Goldberg; W Henderson; C D Robinette
Journal:  Acta Genet Med Gemellol (Roma)       Date:  1987

7.  Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele.

Authors:  G W Small; S T Chen; S Komo; L Ercoli; S Bookheimer; K Miller; H Lavretsky; S Saxena; A Kaplan; D Dorsey; W K Scott; A M Saunders; J L Haines; A D Roses; M A Pericak-Vance
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

8.  Apolipoprotein E and cognitive performance: a meta-analysis.

Authors:  Brent J Small; Christopher B Rosnick; Laura Fratiglioni; Lars Bäckman
Journal:  Psychol Aging       Date:  2004-12

9.  Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults.

Authors:  J D Flory; S B Manuck; R E Ferrell; C M Ryan; M F Muldoon
Journal:  Am J Med Genet       Date:  2000-12-04

10.  No association between apolipoprotein E polymorphisms and general cognitive ability in children.

Authors:  D Turic; P J Fisher; R Plomin; M J Owen
Journal:  Neurosci Lett       Date:  2001-02-16       Impact factor: 3.046

View more
  26 in total

1.  Both odor identification and ApoE-ε4 contribute to normative cognitive aging.

Authors:  Deborah Finkel; Chandra A Reynolds; Maria Larsson; Margaret Gatz; Nancy L Pedersen
Journal:  Psychol Aging       Date:  2011-04-25

2.  APOE ε4 genotype predicts memory for everyday activities.

Authors:  Heather R Bailey; Jesse Q Sargent; Shaney Flores; Petra Nowotny; Alison Goate; Jeffrey M Zacks
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2015-03-10

3.  Meta-analysis of cognitive ability differences by apolipoprotein e genotype in young humans.

Authors:  Gali H Weissberger; Daniel A Nation; Caroline P Nguyen; Mark W Bondi; S Duke Han
Journal:  Neurosci Biobehav Rev       Date:  2018-08-17       Impact factor: 8.989

Review 4.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 5.  Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD.

Authors:  Mark W Jacobson; Linda K McEvoy; Anders Dale; Christine Fennema-Notestine
Journal:  Behav Neurol       Date:  2009       Impact factor: 3.342

6.  The emergence of cognitive discrepancies in preclinical Alzheimer's disease: a six-year case study.

Authors:  Mark W Jacobson; Dean C Delis; Guerry M Peavy; Spencer R Wetter; Erin D Bigler; Tracy J Abildskov; Mark W Bondi; David P Salmon
Journal:  Neurocase       Date:  2009-04-21       Impact factor: 0.881

Review 7.  Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence.

Authors:  F W Sabb; A C Burggren; R G Higier; J Fox; J He; D S Parker; R A Poldrack; W Chu; T D Cannon; N B Freimer; R M Bilder
Journal:  Neuroscience       Date:  2009-05-18       Impact factor: 3.590

Review 8.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 9.  Endophenotypes in normal brain morphology and Alzheimer's disease: a review.

Authors:  C Reitz; R Mayeux
Journal:  Neuroscience       Date:  2009-04-09       Impact factor: 3.590

10.  Pupillary dilation responses as a midlife indicator of risk for Alzheimer's disease: association with Alzheimer's disease polygenic risk.

Authors:  William S Kremen; Matthew S Panizzon; Jeremy A Elman; Eric L Granholm; Ole A Andreassen; Anders M Dale; Nathan A Gillespie; Daniel E Gustavson; Mark W Logue; Michael J Lyons; Michael C Neale; Chandra A Reynolds; Nathan Whitsel; Carol E Franz
Journal:  Neurobiol Aging       Date:  2019-09-09       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.